- Institution: Stanford Univ Med Ctr Lane Med Lib/Periodical Dept/Rm L109
- Sign In as Member / Individual
SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY
Figure 1.
Responsiveness of patients to dexfenfluramine. The percentage of patients from each cohort (drug or placebo) showing more than ten percent loss in body weight (after twelve months) is indicated. Data are simplified from (12).
